Bristol-Myers Squibb Closed Monday At New High For Year
Bristol-Myers Squibb has been on an upward trend since early November and closed Monday at a new high for the year. The company announced after the close Friday that it received FDA approval for the supplemental New Drug Application for ABILIFY, for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years.
For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
For full details on Bristol-Myers Squibb Co (BMY) BMY. Bristol-Myers Squibb Co (BMY) has Short Term PowerRatings at TradingMarkets. Details on Bristol-Myers Squibb Co (BMY) Short Term PowerRatings is available at This Link.
- Research and Markets: Bristol-Myers Squibb Co. - Company PicShot: All That You Need To Know About a Company in a Comprehensively - 02/09/10
- KineMed broadens collaboration with Bristol-Myers - 02/09/10
- KineMed Broadens Collaboration with Bristol-Myers Squibb - 02/08/10
- BRIEF: Bristol-Myers freezing salaries - 02/06/10
- BRIEF: Worker tied to trade-secrets scheme - 02/05/10
- More News >>


